BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in GILD — Gilead Sciences, Inc.
CIK 1520354
Paris, I0
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$497,624,704
-$118,866,503 QoQ
Shares Held
3,938,774
-11.0% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#39
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. GILD ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,624,704 | 3,938,774 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $616,491,207 | 4,423,414 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $450,701,399 | 3,672,001 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $187,621,857 | 1,690,287 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $265,846,413 | 2,397,821 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $308,416,054 | 2,752,486 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $167,338,692 | 1,811,613 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $64,097,356 | 764,520 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $37,943,182 | 553,027 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $48,809,185 | 666,337 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $110,468,233 | 1,363,637 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $73,375,327 | 979,121 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $73,656,492 | 955,709 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $89,769,391 | 1,081,950 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $79,446,619 | 925,412 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $101,363,887 | 1,643,117 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $101,029,618 | 1,634,519 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $97,264,480 | 1,636,072 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $100,109,948 | 1,378,735 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $119,659,685 | 1,713,095 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $139,435,577 | 2,024,914 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $109,906,222 | 1,700,545 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $94,777,192 | 1,626,797 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $109,840,964 | 1,738,265 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $101,078,076 | 1,313,726 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $66,175,308 | 885,170 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||